Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors (Q43054611)
Jump to navigation
Jump to search
scientific article published on 25 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors |
scientific article published on 25 May 2010 |
Statements
1 reference
Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors (English)
1 reference
Alain C Mita
1 reference
Chris H Takimoto
1 reference
Monica Mita
1 reference
Anthony Tolcher
1 reference
Kamalesh Sankhala
1 reference
John Sarantopoulos
1 reference
Manuel Valdivieso
1 reference
Leslie Wood
1 reference
Erik Rasmussen
1 reference
Yu-Nien Sun
1 reference
Z Don Zhong
1 reference
Michael B Bass
1 reference
NgocDiep Le
1 reference
Patricia LoRusso
1 reference
25 May 2010
1 reference
1 reference
Identifiers
1 reference